Clinical Trial: VDyne Transcatheter Tricuspid Valve Replacement Study to Evaluate Safety and Clinical Efficacy in Patients With Symptomatic Severe Tricuspid Valve Regurgitation (TRIVITA Pivotal Trial)

U.S., April 9 -- ClinicalTrials.gov registry received information related to the study (NCT07516444) titled 'VDyne Transcatheter Tricuspid Valve Replacement Study to Evaluate Safety and Clinical Efficacy in Patients With Symptomatic Severe Tricuspid Valve Regurgitation (TRIVITA Pivotal Trial)' on March 25.

Brief Summary: Pivotal trial to evaluate the safety and clinical efficacy of the VDyne System for the treatment of symptomatic severe or greater tricuspid regurgitation.

Study Start Date: June, 2026

Study Type: INTERVENTIONAL

Condition: Tricuspid Valve Regurgitation Tricuspid Valve Disease Cardiovascular Diseases (CVD) Heart Valve Diseases Tricuspid Valve Insufficiency Severe Heart Valve Disease Randomized Controlled Trial (RCT) Symp...